- Home
- CRAN vs CLPT Comparison
CRAN vs CLPT Comparison
Compare CRAN & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRAN | CLPT |
|---|---|---|
| Founded | 2025 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 475.6M | 467.9M |
| IPO Year | 2025 | 2009 |
Fundamental Metrics
Financial Performance| Metric | CRAN | CLPT |
|---|---|---|
| Price | $10.10 | $14.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 170.2K | ★ 550.5K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $9.13 | $8.27 |
| 52 Week High | $10.21 | $30.10 |
Technical Indicators
Market Signals| Indicator | CRAN | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 33.89 | 51.16 |
| Support Level | $9.97 | $14.65 |
| Resistance Level | N/A | $15.29 |
| Average True Range (ATR) | 0.08 | 0.69 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 95.10 | 48.00 |
Price Performance
Historical ComparisonAbout CRAN Crane Harbor Acquisition Corp. II Class A Ordinary Shares
Crane Harbor Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.